Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 ...
-
SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...
-
Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER,...
-
SEATTLE and VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...
-
A pooled Phase 3 analysis of more than 1,600 people who smoke showed high quit rates; including among those who had previously not succeeded with other smoking cessation medications and regardless of...
-
Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Workplace Wellness Market Report 2026" has been added to ResearchAndMarkets.com's offering. The workplace wellness market has experienced robust...
-
Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Health Coaching Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Health Coaching Market Global Report 2026 is an...
-
Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Nicotine Gum Market Report 2026" has been added to ResearchAndMarkets.com's offering. The nicotine gum market has experienced substantial growth,...
-
Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Tobacco Alternative Gums Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tobacco alternative gums market is...
-
SEATTLE and VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development...